About mk2 Biotechnologies
mk2 Biotechnologies is a company based in Munchen (Germany) founded in 2017 by Marco Giuman and Sebastian Mangold.. mk2 Biotechnologies operates in a competitive market with competitors including Encodia, Tierra Biosciences, Amide Technologies, Kesmalea and Aquagene, among others.
- Headquarter Munchen, Germany
- Founders Marco Giuman, Sebastian Mangold
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mk2 Biotechnologies Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
SeedBlink
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Leadership Team
2 people
Product Management Team
2 people
Science Team
1 people
Head Team
1 people
Unlock access to complete
Funding Insights of mk2 Biotechnologies
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Seed - mk2 Biotechnologies | Valuation | OCCIDENT – The Science Investor. |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in mk2 Biotechnologies
mk2 Biotechnologies has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include SeedBlink, Gateway Ventures and OCCIDENT. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are provided to deep-tech startups.
|
Founded Year | Domain | Location | |
|
An online platform is operated for crowdfunding investments in startups.
|
Founded Year | Domain | Location | |
|
Investments in pre-seed and seed-stage startups are facilitated for individuals.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by mk2 Biotechnologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - mk2 Biotechnologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mk2 Biotechnologies Comparisons
Competitors of mk2 Biotechnologies
mk2 Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Encodia, Tierra Biosciences, Amide Technologies, Kesmalea and Aquagene, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Technology platforms for integrative proteomic analysis are developed.
|
|
| domain | founded_year | HQ Location |
AI-based tools for protein development and custom synthesis are offered.
|
|
| domain | founded_year | HQ Location |
Automated peptide synthesis platform is developed with precision reagents.
|
|
| domain | founded_year | HQ Location |
Protein homeostasis modulators are developed for therapeutic applications.
|
|
| domain | founded_year | HQ Location |
Produces high-quality recombinant proteins for research and industrial applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about mk2 Biotechnologies
When was mk2 Biotechnologies founded?
mk2 Biotechnologies was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Where is mk2 Biotechnologies located?
mk2 Biotechnologies is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Who is the current CEO of mk2 Biotechnologies?
Konstantinos Antonopoulos is the current CEO of mk2 Biotechnologies.
What does mk2 Biotechnologies do?
mk2 Biotechnologies was founded in 2017 in Munich, Germany, within the biotechnology sector. A scalable technology for peptide and protein synthesis is utilized, relying on recombinant methods to support production across various chain lengths. Services are provided to clients in research, development, agriculture, and stock breeding, facilitating applications in these fields. Operations focus on enabling large-scale manufacturing for life science needs.
Who are the top competitors of mk2 Biotechnologies?
mk2 Biotechnologies's top competitors include Encodia, Tierra Biosciences and Amide Technologies.
Who are mk2 Biotechnologies's investors?
mk2 Biotechnologies has 3 investors. Key investors include SeedBlink, Gateway Ventures, and OCCIDENT.